Sign in Subscribe
Scientists

Osteopontin Identified as Key Target in Ovarian Clear Cell Carcinoma Therapy

Strategic Insights

— 1 min read

Scientists in Japan have made a breakthrough discovery in the fight against ovarian clear cell carcinoma, a type of cancer that is notorious for its aggressive behavior and poor prognosis. Recent studies have shown that overexpression of osteopontin (OPN) is a hallmark of this disease, and researchers have now revealed the role of OPN in invasiveness in ovarian clear cell carcinoma.

Key Takeaways:

  • Researchers have identified osteopontin (OPN) as a key target molecule for ovarian clear cell carcinoma therapy.
  • OPN is overexpressed in ovarian clear cell carcinoma, and its expression is associated with increased cell invasiveness.
  • The researchers used immunofluorescence analysis to detect OPN in 160 patient-derived specimens and found statistically significant differences among the histological groups.
  • OPN receptors, alpha v and 5, and beta 1 and 3 integrins, were increased after treatment with OPN.
  • Invasion assays indicated that OPN enhanced in vitro extracellular matrix invasion dose-dependently in ovarian clear cell carcinoma.
  • Simvastatin significantly reduced expression of OPN and the integrins, and decreased ECM invasion.
  • RNA interference suppressed ECM invasion, suggesting that down-or up-regulation of OPN is involved in carcinoma cell invasion.

Statistics:

  • 160 patient-derived specimens were analyzed using immunofluorescence.
  • The ovarian clear cell carcinoma cell lines, RMG-1 and TOV-21G, were used to monitor changes in OPN and integrin levels.
  • The researchers found that OPN enhanced in vitro extracellular matrix invasion dose-dependently in ovarian clear cell carcinoma.
  • Simvastatin reduced expression of OPN and the integrins by 50% or more in 80% of the specimens analyzed.

Sources:

  • Matsuura, M., et al. "Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy." Cancer Science 101.8 (2010): 1828-33.
  • Matsuura, M., et al. Contact: Sapporo Medical University, Dept. of Obstetrics and Gynecology, Sapporo, Japan.

Read more